av/torrent-pharmaceuticals--big.svg

NSE:TORNTPHARM

Torrent Pharmaceuticals Limited

  • Stock

INR

Last Close

3,434.55

30/08 10:00

Market Cap

1.00T

Beta: 0.23

Volume Today

993.34K

Avg: 264.27K

PE Ratio

59.48

PFCF: -

Dividend Yield

0.30%

Payout:0%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
9.65B
-
10.37B
7.43%
12.13B
16.97%
14.59B
20.29%
17.63B
20.85%
19.51B
10.67%
20.42B
4.66%
24.15B
18.27%
25.72B
6.50%
23.46B
8.77%
average payables
12.78B
-
16.64B
30.23%
20.97B
26.06%
23.16B
10.43%
21.73B
6.18%
20.72B
4.63%
20.87B
0.69%
20.72B
0.72%
18.71B
9.71%
16.77B
10.37%
average receivables
11.96B
-
17.85B
49.28%
20.12B
12.66%
9.47B
52.90%
9.67B
-
9.67B
0%
8.26B
14.66%
17.30B
109.47%
18.77B
8.52%
book value per share
56.21
-
73.59
30.91%
100.13
36.07%
128.53
28.36%
136.57
6.25%
139.59
2.21%
142.51
2.09%
172.47
21.02%
175.89
1.98%
183.15
4.13%
capex per share
-11.82
-
-7.17
39.37%
-17.85
149.01%
-14.38
19.41%
-23.38
62.54%
-19.58
16.23%
-12.02
38.63%
-9.90
17.61%
-5.99
39.56%
-16.96
183.39%
capex to depreciation
-4.60
-
-1.27
72.35%
-2.45
93.03%
-1.59
35.39%
-1.94
22.09%
-1.07
44.59%
-0.62
42.07%
-0.51
18.04%
-0.31
39.94%
-0.81
165.30%
capex to operating cash flow
-0.67
-
-0.30
55.14%
-0.22
25.64%
-0.48
115.93%
-0.88
84.08%
-0.37
58.34%
-0.29
20.71%
-0.17
42.97%
-0.11
32.60%
-0.24
115.75%
capex to revenue
-0.10
-
-0.05
46.61%
-0.09
74.89%
-0.09
7.37%
-0.14
57.40%
-0.09
34.24%
-0.05
41.14%
-0.04
18.72%
-0.02
43.38%
-0.06
152.06%
cash per share
28.19
-
25.51
9.52%
41.52
62.78%
50.05
20.55%
40.17
19.74%
34.49
14.13%
19.57
43.26%
21.81
11.43%
17.22
21.01%
24.67
43.25%
days of inventory on hand
282.37
-
264.16
6.45%
300.77
13.86%
301.33
0.19%
403.92
34.05%
304.23
24.68%
348.10
14.42%
437.81
25.77%
354.19
19.10%
297.61
15.98%
days payables outstanding
411.83
-
460.46
11.81%
517.02
12.28%
444.10
14.10%
420.76
5.26%
329.64
21.66%
336.54
2.09%
337.49
0.28%
240.86
28.63%
224.07
6.97%
days sales outstanding
130.59
-
169.65
29.90%
106.09
37.46%
94.65
-
76.43
-
78.37
2.55%
75.05
4.24%
debt to assets
0.22
-
0.35
55.17%
0.26
24.24%
0.25
5.53%
0.45
83.01%
0.43
5.76%
0.42
2.71%
0.35
16.76%
0.31
10.29%
0.36
15.10%
debt to equity
0.59
-
1.10
84.95%
0.70
36.57%
0.58
17.32%
1.40
142.30%
1.28
8.58%
1.21
5.26%
0.84
31.04%
0.68
18.13%
0.87
26.69%
dividend yield
0.03
-
0.01
66.21%
0.04
263.51%
0.01
79.06%
0.01
59.39%
0.01
22.04%
0.02
123.55%
0.01
63.51%
0.01
82.31%
0.02
15.80%
earnings yield
0.07
-
0.04
48.82%
0.08
98.28%
0.04
53.21%
0.03
10.94%
0.01
57.12%
0.03
126.32%
0.03
5.35%
0.02
43.41%
0.02
45.50%
enterprise value
92.35B
-
217.81B
135.85%
244.01B
12.03%
285.05B
16.82%
276.51B
3.00%
376.01B
35.99%
385.46B
2.51%
473.70B
22.89%
509.17B
7.49%
568.78B
11.71%
enterprise value over ebitda
9.64
-
17.16
78.08%
8.48
50.58%
18.54
118.62%
17.37
6.28%
18.79
8.14%
17.03
9.33%
18.76
10.14%
19.47
3.77%
19.70
1.20%
ev to operating cash flow
15.41
-
26.88
74.49%
8.99
66.55%
28.15
212.98%
30.92
9.86%
20.91
32.37%
27.69
32.44%
23.56
14.93%
28.24
19.87%
24.02
14.95%
ev to sales
2.29
-
4.76
107.70%
3.74
21.32%
5.03
34.27%
4.72
6.06%
5.04
6.74%
4.95
1.68%
6.01
21.24%
6.05
0.69%
6.01
0.63%
free cash flow per share
5.89
-
16.77
184.75%
62.32
271.58%
15.54
75.07%
3.04
80.43%
33.54
1,002.93%
29.10
13.23%
49.51
70.10%
47.29
4.48%
53.01
12.11%
free cash flow yield
0.02
-
0.03
28.85%
0.09
221.22%
0.02
78.48%
0.00
76.00%
0.04
635.12%
0.03
16.40%
0.04
31.79%
0.03
12.93%
0.03
1.81%
graham net net
-18.55
-
-71.72
286.55%
-62.60
12.70%
-97.53
55.79%
-215.04
120.48%
-171.68
20.16%
-220.96
28.70%
-145.38
34.20%
-117.51
19.17%
-159.70
35.91%
graham number
157.51
-
191.67
21.69%
338.61
76.66%
282.44
16.59%
248.13
12.15%
201.21
18.91%
311.58
54.85%
378.87
21.59%
301.46
20.43%
389.37
29.16%
income quality
0.71
-
0.86
21.38%
1.15
33.15%
0.93
18.92%
0.96
3.19%
3.20
233.32%
1.17
63.36%
1.32
12.31%
1.47
11.64%
1.28
12.83%
intangibles to total assets
0.01
-
0.24
4,179.16%
0.21
13.83%
0.18
13.79%
0.40
121.50%
0.36
9.41%
0.34
6.72%
0.31
8.51%
0.29
5.47%
0.36
24.44%
interest coverage
27.82
-
5.32
80.88%
13.86
160.58%
5.34
61.47%
3.09
42.22%
2.73
11.50%
3.59
31.36%
5.24
46.13%
7.72
47.32%
6.55
15.24%
interest debt per share
34.45
-
85.58
148.39%
75.24
12.08%
80.16
6.55%
199.95
149.43%
193.21
3.37%
185.80
3.84%
154.54
16.83%
127.72
17.35%
168.47
31.90%
inventory turnover
1.29
-
1.38
6.89%
1.21
12.17%
1.21
0.19%
0.90
25.40%
1.20
32.77%
1.05
12.60%
0.83
20.49%
1.03
23.61%
1.23
19.01%
invested capital
0.59
-
1.10
84.95%
0.70
36.57%
0.58
17.32%
1.40
142.30%
1.28
8.58%
1.21
5.26%
0.84
31.04%
0.68
18.13%
0.87
26.69%
market cap
88.72B
-
196.06B
121.00%
226.80B
15.68%
262.74B
15.84%
214.29B
18.44%
321.51B
50.03%
333.67B
3.78%
430.68B
29.07%
472.46B
9.70%
520.18B
10.10%
net current asset value
2.38B
-
-13.61B
673.22%
-9.62B
29.35%
-3.90B
59.43%
-43.58B
1,016.71%
-43.59B
0.02%
-42.06B
3.52%
-27.16B
35.42%
-19.82B
27.03%
-35B
76.60%
net debt to ebitda
0.38
-
1.71
351.90%
0.60
65.11%
1.45
142.68%
3.91
169.41%
2.72
30.35%
2.29
15.96%
1.70
25.55%
1.40
17.60%
1.68
19.93%
net income per share
19.62
-
22.19
13.11%
50.89
129.36%
27.58
45.80%
20.04
27.36%
12.89
35.66%
30.28
134.88%
36.99
22.17%
22.96
37.92%
36.79
60.21%
operating cash flow per share
17.71
-
23.94
35.16%
80.17
234.88%
29.92
62.68%
26.42
11.70%
53.13
101.09%
41.12
22.60%
59.41
44.47%
53.27
10.33%
69.97
31.35%
payables turnover
0.89
-
0.79
10.56%
0.71
10.94%
0.82
16.42%
0.87
5.55%
1.11
27.64%
1.08
2.05%
1.08
0.28%
1.52
40.12%
1.63
7.49%
receivables turnover
2.79
-
2.15
23.02%
3.44
59.91%
3.86
-
4.78
-
4.66
2.48%
4.86
4.43%
research and ddevelopement to revenue
0.00
-
0.00
24.18%
0.00
36.92%
0.01
-
0.00
73.15%
0.00
43.78%
0.00
28.03%
return on tangible assets
0.13
-
0.13
4.96%
0.24
92.82%
0.11
53.44%
0.08
29.68%
0.05
38.90%
0.11
127.66%
0.13
16.82%
0.08
34.88%
0.13
55.34%
revenue per share
119.14
-
135.29
13.55%
192.63
42.38%
167.59
13.00%
173.06
3.26%
220.47
27.39%
229.87
4.26%
233.01
1.37%
248.75
6.75%
279.66
12.43%
roe
0.35
-
0.30
13.60%
0.51
68.56%
0.21
57.77%
0.15
31.64%
0.09
37.05%
0.21
130.06%
0.21
0.95%
0.13
39.13%
0.20
53.86%
roic
0.25
-
0.13
48.69%
0.32
150.84%
0.14
57.35%
0.06
54.40%
0.10
59.82%
0.13
31.19%
0.14
9.83%
0.12
13.63%
0.13
2.71%
sales general and administrative to revenue
0.04
-
0.05
20.16%
0.03
29.99%
0.08
142.25%
0.10
24.76%
0.08
18.02%
0.08
4.71%
0.07
5.76%
0.07
10.29%
0.06
1.60%
shareholders equity per share
56.21
-
73.59
30.91%
100.13
36.07%
128.53
28.36%
136.57
6.25%
139.59
2.21%
142.51
2.09%
172.47
21.02%
175.89
1.98%
183.15
4.13%
stock based compensation to revenue
tangible asset value
18.74B
-
5.80B
69.06%
15.13B
160.92%
25.34B
67.43%
-10.39B
141.01%
-3.60B
65.30%
1.08B
129.98%
15.12B
1,298.75%
21.47B
42.03%
7.71B
64.10%
tangible book value per share
55.38
-
17.14
69.06%
44.71
160.92%
74.86
67.43%
-30.70
141.01%
-10.65
65.30%
3.19
129.98%
44.67
1,298.75%
63.45
42.03%
22.78
64.09%
working capital
12.30B
-
12.28B
0.18%
13.78B
12.24%
22.23B
61.33%
601.50M
97.29%
-1.28B
312.44%
-4.73B
270.36%
6.30B
233.10%
7.50B
19.05%
-1.33B
117.74%

All numbers in INR (except ratios and percentages)